UBS Group’s Progyny PGNY Stock Holding History

UBS Group’s Portfolio PGNY Stock Details PGNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-25,000	Closed	-$803K	–	9460
2023 Q1	$803K	Hold	25,000	–	–	﹤0.01%	4291
2022 Q4	$779K	Buy	+25,000	New	+$904K	﹤0.01%	4302

Other funds holding PGNY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

UBS Group's PGNY Position: Q2 2026 in Review

UBS Group reduced its Progyny (PGNY) stake by 18% in Q2 2026, selling an estimated $1.49M and leaving 307,970 shares worth $8.88M. The position accounts for ﹤0.01% of the portfolio, ranked #3580.

UBS Group first reported a position in PGNY in Q4 2019 and has held it in 27 quarters since. 311 funds tracked by Wall St. Rank hold PGNY as of Q2 2026.

UBS Group held 307,970 shares of Progyny worth $8.88M as of Q2 2026.
UBS Group sold 66,474 Progyny shares in Q2 2026, an estimated $1.49M.
Progyny made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #3580 holding.
UBS Group first reported a position in Progyny in Q4 2019 and has held it in 27 quarters since.
311 funds tracked by Wall St. Rank held Progyny as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.